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Background: Ligation-assisted endoscopic enucleation (EE-L) was developed for the pathological diagnosis and
resection of small gastrointestinal tumors originating from the muscularis propria. The technique combines
endoscopic band ligation and endoscopic enucleation. The aim of this study was to evaluate the efficacy and safety
of EE-L in the diagnosis and resection of gastrointestinal tumors originating from the muscularis propria.
Methods: A total of 43 patients were eligible for inclusion in this study from June 2009 to June 2011. Endoscopic
ligation was first performed to force the tumor to assume a polypoid form with a pseudostalk. EE-L was then
performed until the tumor was completely enucleated from the muscularis propria. Wound closure was performed
using clips and adhesive tissue.
Results: All 43 tumors were completely enucleated. The mean enucleation time was 7.2 minutes (range, 5–11 minutes).
No perforation, massive hemorrhage, or peritonitis requiring further endoscopic or surgical intervention occurred.
Histopathology, 19 lesions were identified as gastrointestinal stromal tumors and 24 lesions were identified as
leiomyomas. The mean follow-up time was 20.4 months (range, 14–38 months). No recurrence has occurred during the
follow-up period.
Conclusions: EE-L appears to be a safe, effective, and relatively simple method for the histologic diagnosis and removal
of small gastrointestinal tumors originating from the muscularis propria.
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Some gastrointestinal tumors originating from the muscu-
laris propria, such as gastrointestinal stromal tumors
(GISTs), may be nonmalignant when diagnosed but have
the potential to undergo malignant transformation. A ma-
jority of patients with gastrointestinal lesions originating
from the muscularis propria prefer to undergo resection
despite controversies over therapeutic decisions. Several
endoscopic resection techniques have been proven feasible
and safe for tumors originating from the muscularis
propria, including endoscopic submucosal dissection [1-4],* Correspondence: sunsiyucmu@yahoo.com.cn
1Endoscopic Center, Shengjing Hospital of China Medical University,
No. 36 Sanhao Street, Shenyang, Liaoning Province 110004, China
Full list of author information is available at the end of the article
© 2013 Guo et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the orendoscopic enucleation [5,6], endoscopic ligation [7-9],
endoscopic ligation and resection [10], endoscopic full-
thickness resection [11], and submucosal tunneling endo-
scopic resection [12,13].
Ligation-assisted endoscopic enucleation (EE-L) was de-
veloped by combining endoscopic band ligation and endo-
scopic enucleation to fully exploit the advantages of each
technique. The present study investigated the efficacy and
safety of EE-L in the diagnosis and resection of gastro-
intestinal tumors originating from the muscularis propria.Methods
Patients
Patients who underwent EE-L for gastrointestinal tumors
originating from the muscularis propria at Shengjing. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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June 2011 were enrolled in this study. To be included in
the study, the tumors had to originate in the muscularis
propria layer of the gastrointestinal wall, and this had to
be confirmed by endoscopic ultrasonography (EUS). All
tumors eligible for participation based on EUS examina-
tion were no more than 10 mm in diameter because the
diameter of the air-driven ligator cap was 10 mm. All pa-
tients in this series had a normal complete blood cell
count and thrombin time without having taken warfarin,
clopidogrel, aspirin, or any other nonsteroidal anti-
inflammatory drug for at least 1 week before the procedure.
This study was approved by the Institutional Review
Board and Ethics Committee of China Medical University.
All patients voluntarily chose their therapeutic course and
provided written informed consent for their participation
in this study. The operator performing the EE-L procedure
in this study was familiar with both the endoscopic
ligation and submucosal dissection techniques.Devices
Endoscopic ultrasound was performed with a linear-array
scanning echoendoscope (Pentax EG3870UT equipped
with a HITACHI 6500 EUB ultrasonography machine) or
a radical scanning echoendoscope (SP-701; Fujinon).
Endoscopic ligation was performed with a standard endo-
scope (EPK-I; Pentax) with a 10-mm air-driven ligator cap
(Sumibe, Akita, Japan). This ligator cap had a small tube
to control the band, which was released after 2 ml of air
had been injected into the tube. EE-L was performed using
equipment including a hook knife (KD-620LR; Olympus),Figure 1 EE-L for gastric tumor originating from muscularis propria laye
elastic band. C Images of tumor after exposure and after resection (inset). D T
covered by tissue adhesive (white arrow, inset). E Wound surface 5 days after
clips, and tissue adhesive (black arrow); wound surface 1 month after EE-L sho
after EE-L showing the scar. Endoscopic view (black arrow) and EUS view (whinjection needle (NM-4L-1; Olympus), forceps, snare (SD-
9L-1; Olympus), hemostatic forceps (FD-410LR; Olympus),
and high-frequency generator (ICC 200; Erbe, Tübingen,
Germany). Wound closure was performed with endoclips
(HX-600-135; Olympus) and tissue adhesive composed
mainly of alkyl alpha-cyanoacrylate (Beijing Suncon Med-
ical Adhesive Co., Beijing, China). About 1.5 to 3.0 ml of
adhesive was sprayed evenly over the wound by endo-
scopic catheters that were placed in the stomach and
aimed at the wound surface.Procedure
The lesion was first aspirated into the transparent cap
attached to the tip of endoscope. The elastic band was
then released around its base (Figures 1A, B; 2A, B). The
purpose of ligation was to force the lesion to assume a
polypoid form with a pseudostalk. EUS was used to de-
termine whether the hypoechoic mass had been com-
pletely confined within the band. If the lesion was not
completely ligated, the band was removed with a foreign
body forceps and the lesion was ligated again. After the
mucosal and submucosal layers overlying the tumor had
been cut open with hook knife, the exposed tumor was
gradually dissected from the muscularis propria layer by
the hook knife and\or forceps (Figures 1C, D; 2C-E).
When the tumor had been completely exposed, an elec-
trocautery snare was used in some cases for the last step
of the excision. After the wound had been carefully eval-
uated to ensure the absence of residual tumor tissue, the
wound was closed with metallic clips and tissue adhesive
was sprayed on the clips (Figure 1E, F). The patientsr. A Images of tumor prior to banding. B Image of tumor ligated by an
he wound surface was closed with metallic clips (black arrow) and then
EE-L showing the wound surface covered with the elastic band, metallic
wing the iatrogenic ulcer (white arrow, inset). F Wound surface 2 months
ite arrow, inset).
Figure 2 EE-L for rectal tumor originating from the muscularis propria layer. A Images of rectum tumor prior to banding. B Image of
tumor ligated by an elastic band. C Image of exposed tumor. D Images of tumor completely enucleated and then resected (inset).
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cers had completely healed.
Pathologic examination included identification of cell
type, overall cellularity, nuclear atypia, immunohistochem-
ical findings, and the mitotic index. Immunohistochemical
analysis for CD117 (c-kit), CD34, smooth muscle actin,
desmin, S-100, etc. were performed to differentiate tumors
of mesenchymal origin.
Endoscopic examinations were performed 5 days after
the procedure to examine the wound surface and again
2 months after the resection to assess ulcer healing. To
confirm the completeness of tumor resection, endoscopic
examinations were performed for all patients once a year
for the first 2 years. If no residual tumor or tumor recur-
rence was found, the patients diagnosed with leiomyomas
required no further treatment; the patients diagnosed with
GISTs were advised to undergo endoscopic examinations
once every 2 years. If residual tumor or tumor recurrence
was detected, EE-L could be performed.
Results
From June 2009 to June 2011, a total of 43 patients with
43 tumors underwent EE-L at Shengjing Hospital of
China Medical University. Patient demographic charac-
teristics, lesion features, pathological diagnosis, and clin-
ical outcomes are summarized in Table 1. None of the
patients included in the study had significant symptoms.
All 43 gastrointestinal tumors were resected by EE-L.
The mean operation time was 27.9 minutes (range, 16–40 minutes), and the mean enucleation time was 7.2 min-
utes (range, 5–11 minutes). One patient experienced self-
limiting, non-life-threatening hemorrhage 5 days after
EE-L. No perforation, massive hemorrhage, or peritonitis
requiring further endoscopic or surgical intervention oc-
curred. The mean follow-up time was 20.4 months
(range, 14–38 months). No recurrence has occurred dur-
ing the follow-up period.
The histological diagnoses obtained for the 43 lesions
were 24 leiomyomas and 19 GISTs. Mitotic counts in all
19 GISTs were <5 per 50 high-power fields; thus, all were
classified as very low-risk.
Discussion
Gastrointestinal tumors of muscularis propria origin in-
clude leiomyomas, GISTs, neural tumors, and others.
GISTs are the most common mesenchymal tumors of
the gastrointestinal tract. Large GISTs with high mitotic
rates are often associated with malignant behavior and
display higher rates of recurrence and metastasis [14-18].
Therefore, the presence of such lesions can become a psy-
chological burden to patients, even if the lesions are very
small. For these reasons, some patients with such lesions
prefer to undergo resection, although the management of
small, incidentally discovered GISTs of <2 cm is contro-
versial [19,20]. A histologic diagnosis of these lesions is
sometimes needed [19-21]. EUS-guided sampling, deep bi-
opsy, and endoscopic partial resection with the unroofing
technique are feasible and effective procedures with which
Table 1 Demographic and clinicopathological characteristics of the study patients (N = 43)









1 F/45 Fundus, PW 9 × 6 6 30 Leiomyoma None
2 M/48 Body, LC 8 × 7 7 33 GIST None
3 M/37 Body, PW 10 × 4 7 38 Leiomyoma None
4 F/65 Cardia 9 × 5 5 39 Leiomyoma None
5 M/38 Body, AW 10 × 7 10 40 Leiomyoma None
6 F/56 Fundus, PW 9 × 8 5 25 GIST None
7 M/44 Fundus, PW 9 × 8 6 34 GIST None
8 F/51 Body, LC 10 × 6 8 29 Leiomyoma None
9 F/50 Body, LC 10 × 8 9 25 GIST None
10 M/60 Fundus, PW 8 × 6 10 30 Leiomyoma None
11 M/39 Body, PW 6 × 5 11 32 GIST None
12 F/43 Body, PW 9 × 5 8 32 Leiomyoma None
13 F/31 Cardia 9 × 8 7 26 GIST None
14 M/56 Fundus, PW 10 × 7 5 30 GIST None
15 M/47 Body, GC 5 × 4 8 28 Leiomyoma None
16 F/48 Cardia 10 × 8 9 27 GIST Bleeding
17 M/53 Fundus, PW 9 × 7 10 32 Leiomyoma None
18 M/55 Fundus, PW 7 × 6 11 28 Leiomyoma None
19 F/68 Body, PW 8 × 5 5 27 Leiomyoma None
20 M/59 Rectum 9 × 8 5 23 GIST None
21 F/27 Body, LC 9 × 4 7 26 Leiomyoma None
22 M/36 Fundus, PW 10 × 8 8 22 GIST None
23 F/54 Body, PW 8 × 5 9 29 Leiomyoma None
24 M/32 Cardia 10 × 9 6 25 GIST None
25 M/35 Body, PW 9 × 6 5 20 Leiomyoma None
26 F/53 Antrum, PW 8 × 7 7 23 GIST None
27 M/29 Body, LC 10 × 7 8 27 Leiomyoma None
28 M/46 Fundus, GC 9 × 5 10 32 Leiomyoma None
29 F/49 Fundus, PW 10 × 5 11 29 Leiomyoma None
30 M/36 Body, AW 9 × 8 8 27 GIST None
31 F/47 Fundus, PW 8 × 7 6 24 GIST None
32 F/48 Cardia 9 × 6 5 19 Leiomyoma None
33 M/52 Body, PW 10 × 6 7 21 Leiomyoma None
34 F/51 Body, LC 9 × 8 5 32 GIST None
35 M/47 Rectum 10 × 9 6 32 Leiomyoma None
36 M/36 Fundus, PW 9 × 5 5 26 Leiomyoma None
37 F/53 Fundus, PW 10 × 8 7 30 GIST None
38 M/49 Body, PW 10 × 8 8 32 GIST None
39 F/43 Body, LC 8 × 4 5 32 Leiomyoma None
40 F/28 Cardia 9 × 7 5 25 GIST None
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Table 1 Demographic and clinicopathological characteristics of the study patients (N = 43) (Continued)
41 F/48 Body, PW 10 × 6 6 16 Leiomyoma None
42 M/37 Cardia 8 × 7 6 19 Leiomyoma None
43 F/49 Fundus, PW 7 × 6 7 23 GIST None
GIST, gastrointestinal stromal tumor; PW, posterior wall; AW, anterior wall; LC, lesser curvature; GC, greater curvature.
Note: We have received consent from each patient to publish this specific information.
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thelial tumors originating from the muscularis propria
[22-26]. However, these biopsy procedures are difficult for
small tumors [19,20], especially those smaller than 10 mm.
The true malignant potential for individual GISTs cannot
be accurately determined using current imaging and non-
invasive sampling methods [27].
Laparoscopic resection appears to be a safe and effect-
ive alternative method for the treatment of gastric tu-
mors [28]. However, its application to small tumors is
limited, especially those less than 10 mm. Several endo-
scopic resection techniques have potential advantages
for small lesions originating from the muscularis propria.
Endoscopic band ligation is a simple, effective, and safe
procedure for treating gastrointestinal submucosal tu-
mors of less than 10 mm, although it does not allow for
a complete pathological examination because the tumor
mass is exfoliated directly into the lumen and excreted
[7,8]. Endoscopic enucleation or endoscopic submucosal
dissection using an insulated-tip knife, hook knife, for-
ceps, or electrocautery snare may have the advantage of
providing both a pathological diagnosis and clinical
treatment for such lesions in selected patients [1-6].
However, these techniques usually require highly skill-
ful manipulation by experienced specialists and rela-
tively longer procedure times [1-6,29]. In one study, the
complete resection rate for small tumors, especially those
smaller than 1 cm, was lower than that for larger tumors
[5]. It was more difficult to strip the covering mucosa and
dissect the submucosal layer in the small tumors [5].
Ligation-assisted endoscopic mucosal resection is one
of several endoscopic treatment modalities employed in
the treatment of esophageal neoplasia [30]. Endoscopic
submucosal resection with a ligation device was suc-
cessfully performed in all 25 esophageal subepithelial
tumors localized within the muscularis mucosa or
submucosa by Lee et al. [31], and the en bloc resec-
tion rate was 100% (25 of 25 tumors). Endoscopic ligation
and resection shows promise as a safe and feasible tech-
nique with which to treat small EUS-suspected gastric
GISTs [10].
EE-L was developed for the diagnosis and treatment of
small gastrointestinal lesions originating from the mus-
cularis propria. This technique combines endoscopic
band ligation and endoscopic enucleation to fully exploit
the advantages of each technique.Endoscopic band ligation of the tumor simplifies the
endoscopic enucleation procedure and reduces the time
required because the elastic bands firmly ligate the lesions
and cause them to assume a polypoid form with pseu-
dostalks during the entire enucleation process. After the
tumor has been ligated, the overall endoscopic enucleation
process progresses easily and smoothly. The enucleation
time in the present study was short (mean, 7.2 minutes;
range, 5–11 minutes).
Perforation is a recognized complication during endo-
scopic resection, even in the hands of an expert endos-
copist [1-6]. The EE-L technique may substantially
decrease the risk of perforation during the enucleation
process. First, the base below the tumor is firmly ligated
by the elastic band. Second, precutting the overlying
mucosa and submucosa above the tumor and then grad-
ually enucleating the tumor maintains the major overly-
ing mucosa, facilitating the wound closure procedure
and promoting wound healing [2]. Third, closing the
wound with clips and tissue adhesives prevents perfor-
ation and promotes wound healing. Clips have been
widely applied for wound closure of the gastrointestinal
tract to prevent perforation and bleeding [32-35].
Tissue adhesives are used for a variety of local applica-
tions including hemostasis, wound closure, and fistula
repair. The most commonly utilized tissue adhesives in
gastrointestinal endoscopy include cyanoacrylates, fibrin
glues, and thrombin. Cyanoacrylates are widely used
outside of the United States for gastric variceal bleeding
and, to a lesser extent, ulcer bleeding and fistula closure
[36]. Tissue adhesives sprayed onto the surface of the clips
and wound firmly immobilize the clips onto the wound.
This not only effectively prevents perforation, but also pre-
vents bleeding from the iatrogenic ulcers [37,38].
This study has some limitations. Like other endoscopic
resection techniques for removal of tumors arising from
the muscularis propria, EE-L is limited in that complete
enucleation is defined solely by endoscopic observation.
It was impossible to remove tumor tissue with a suffi-
ciently safe margin using endoscopic resection. Therefore,
long-term follow-up assessment should be performed to
ensure the complete removal of GISTs. Although endo-
scopic resection cannot completely eliminate the need for
continued surveillance in all patients, it can eliminate the
need for surveillance in patients with leiomyomas. For
patients with GISTs in this study, endoscopic resection
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servation, and no residual tumor or tumor recurrence
was found during the long-term follow-up.
Conclusions
This study shows that EE-L appears to be a safe, effect-
ive, and relatively simple technique for the pathological
diagnosis and resection of small gastrointestinal tumors
originating from the muscularis propria. Controlled clin-
ical trials with larger sample sizes and longer follow-up
periods are necessary to further examine the value and
limitations of this technique.
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